Skip to main content

North Carolina Biotech Newsletter

 

April 2014

About NC

|

Contact Us

|

Tw

|

Fb

|

 

TOP NEWS STORIES from the North Carolina Biotechnology Center

Aerial hears a cool Jazz $400M wake-up call

Stephen Butts, President, COO and Co-Founder of Aerial Biopharma. Courtesy of CED

Aerial BioPharma of Morrisville has sold rights to its clinical-stage narcolepsy drug, ADX-N05, for a potential $397 million to Jazz Pharmaceuticals of Dublin, Ireland.

Read more 


Blackstone firms raise $48M in 2013

A young Triangle medical device company started with the help of a North Carolina Biotechnology Center loan, and another helped with an NC IDEA grant, are among eight members of the Blackstone Entrepreneurs Network (BEN) that raised nearly $48 million in funding during 2013.

Read more


Argos Hits $45M IPO

Argos Therapeutics has joined the growing ranks of companies bootstrapped by North Carolina Biotechnology Center funding that have gone on to become publicly traded, hitting the NASDAQ market at $8 a share to raise $45 million.

Read more


NCBiotech helps 3 rising stars

Three young bioscience companies started with funding and other help from the North Carolina Biotechnology Center will be presenters at the Innovation Showcase Feb. 26 during the 2014 CED Life Science Conference in Raleigh.

Read more


Eboo picked for Fox foundation program

Durham-based Eboo Pharmaceuticals Inc. (EPI) is one of three U.S. biopharmaceutical companies selected by The Michael J. Fox Foundation for Parkinson’s Research (MJFF) for its Partnering Program.

Read more
 

Company Spotlight

 

 

Charlotte biopharmaceutical company Chelsea Therapeutics hit paydirt on a market approval recommendation by the U.S. Food and Drug Administration for NORTHERA, Chelsea’s first product.

Photo from shutterstock.com

Read more